These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 753259)

  • 21. Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.
    Argiolas A; Paglietti E; Fadda F; Quarantotti BP; Gessa GL
    Life Sci; 1978 Feb; 22(6):461-6. PubMed ID: 625191
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduction by beta-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus.
    Wilkes MM; Yen SS
    Life Sci; 1980 Oct; 27(15):1387-91. PubMed ID: 6255276
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of LSD and 2-bromo LSD on striatal DOPAC levels.
    Persson SA
    Life Sci; 1977 Apr; 20(7):1199-205. PubMed ID: 15175
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of anxiolytic drugs on the catecholamine and DOPAC (3, 4-dihydroxyphenylacetic acid) levels in brain cortical areas and on corticosterone and prolactin secretion in rats subjected to stress.
    Fekete MI; Szentendrei T; Kanyicska B; Palkovits M
    Psychoneuroendocrinology; 1981; 6(2):113-20. PubMed ID: 6119720
    [No Abstract]   [Full Text] [Related]  

  • 25. The trained circling rat: a model for inducing unilateral caudate dopamine metabolism.
    Yamamoto BK; Freed CR
    Nature; 1982 Jul; 298(5873):467-8. PubMed ID: 7088191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prolintane on 3,4-dihydroxyphenylacetic acid concentration in rat brain after spiperone treatment.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1979 Apr; 10(4):561-3. PubMed ID: 572552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress and the mesocorticolimbic dopamine systems.
    Roth RH; Tam SY; Ida Y; Yang JX; Deutch AY
    Ann N Y Acad Sci; 1988; 537():138-47. PubMed ID: 3059920
    [No Abstract]   [Full Text] [Related]  

  • 28. Stress and enhanced dopamine utilization in the frontal cortex: the myth and the reality.
    Antelman SM; Knopf S; Caggiula AR; Kocan D; Lysle DT; Edwards DJ
    Ann N Y Acad Sci; 1988; 537():262-72. PubMed ID: 3059928
    [No Abstract]   [Full Text] [Related]  

  • 29. Food-related stimuli increase the ratio of 3,4-dihydroxyphenylacetic acid to dopamine in the hypothalamus.
    Simansky KJ; Bourbonais KA; Smith GP
    Pharmacol Biochem Behav; 1985 Aug; 23(2):253-8. PubMed ID: 4059311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymology and subcellular localization of aldehyde oxidation in rat liver. Oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4-dihydroxyphenylacetic acid.
    Tank AW; Weiner H; Thurman JA
    Biochem Pharmacol; 1981 Dec; 30(24):3265-75. PubMed ID: 7034733
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo electrochemical detection of catechols in the neostriatum of anaesthetized rats: dopamine or DOPAC?
    Gonon F; Buda M; Cespuglio R; Jouvet M; Pujol JF
    Nature; 1980 Aug; 286(5776):902-4. PubMed ID: 7412872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevation of 3, 4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites.
    Fuller RW; Perry KW; Clemens JA
    J Pharm Pharmacol; 1976 Aug; 28(8):643-4. PubMed ID: 11315
    [No Abstract]   [Full Text] [Related]  

  • 34. Foot-shock stress accelerates non-striatal dopamine synthesis without activating tyrosine hydroxylase.
    Tissari AH; Argiolas A; Fadda F; Serra G; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):155-7. PubMed ID: 41189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic changes in dopamine and DOPAC content, and tyrosine hydroxylase activity in the retina of a cichlid fish.
    Wulle I; Kirsch M; Wagner HJ
    Brain Res; 1990 May; 515(1-2):163-7. PubMed ID: 1972642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in catecholamine concentrations in the hypothalamus and region of the midbrain raphe in male and female rats during postnatal development.
    Stanley HF; Watts AG
    Neurosci Lett; 1985 Nov; 62(1):75-80. PubMed ID: 4069456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of electroshock on dopamine metabolism in rat brain.
    Engel J; Hanson LC; Roos BE; Strömbergsson LE
    Psychopharmacologia; 1968; 13(2):140-4. PubMed ID: 5692714
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of shock-induced fighting and social factors on dopamine turnover in cortical and limbic areas in the rat.
    Dantzer R; Guilloneau D; Mormède P; Herman JP; Le Moal M
    Pharmacol Biochem Behav; 1984 Mar; 20(3):331-5. PubMed ID: 6538686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of 3,4-dihydroxyphenylacetic acid concentration by L-5-hydroxytryptophan in control and fluoxetine-pretreated rats.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1981 Jun; 33(6):406-7. PubMed ID: 6115023
    [No Abstract]   [Full Text] [Related]  

  • 40. L-Tyrosine enhancement of the elevation of 3,4-dihydroxyphenylacetic acid concentration in rat brain by spiperone and amfonelic acid.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1982 Feb; 34(2):117-8. PubMed ID: 6121871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.